Literature DB >> 11686320

Human thrombi contain an abundance of active thrombin.

N J Mutch1, L A Robbie, N A Booth.   

Abstract

This study assessed the abundance and activity of thrombin in human thrombi. removed at autopsy or during surgery. Arterial and venous thrombus sections showed thrombin activity by in situ zymography, based on conversion of fibrinogen to fibrin. Hirudin or antibodies to thrombin abolished the activity. Thrombin activity in extracts of 40 thrombi was quantified by cleavage of fibrinogen or small peptide substrates: the results correlated well (r = 0.87, p<0.0001) with a median activity of about 4.5 IU/g of thrombus (wet weight). Activity correlated poorly with total prothrombin (median 27 microg/g) and was inversely related to antithrombin, but not to PAI-1. Zymography showed two major active bands, thrombin at 37 kDa, and a 50 kDa form that probably corresponds to meizothrombin desF1. The abundant local thrombin demonstrated here has implications for thrombus lysis and extension: incomplete lysis and exposure of active thrombin may lead to re-occlusion of vessels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686320

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

2.  Cytokine and growth factor concentration in cerebrospinal fluid from patients with hydrocephalus following endovascular embolization of unruptured aneurysms in comparison with other types of hydrocephalus.

Authors:  Monika Killer; Adam Arthur; Abdul Rahman Al-Schameri; John Barr; Donald Elbert; Gunther Ladurner; Julie Shum; Gregory Cruise
Journal:  Neurochem Res       Date:  2010-07-03       Impact factor: 3.996

Review 3.  Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Authors:  J L Willemse; E Heylen; M E Nesheim; D F Hendriks
Journal:  J Thromb Haemost       Date:  2009-08-28       Impact factor: 5.824

4.  Lethal End of Spectrum of Clots-Thrombotic Storm.

Authors:  Muhammad Asim Rana; Ahmed F Mady; Abdullah Ali Lashari; Rehab Eltreafi; Nicola Fischer-Orr; Kamal Naser
Journal:  Case Rep Crit Care       Date:  2018-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.